Skip to content

Research on Key Issues in Drug Label Update based on the Evaluation of Generic Drug Conformance

Study on Key Issues of Drug Lable Update Based on the Evaluation of Generic Drug Conformance

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016231
Enrollment
Unknown
Registered
2018-05-21
Start date
2018-05-28
Completion date
Unknown
Last updated
2018-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

multiple diseases

Interventions

Case series:Nil

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: comply with the inclusion criteria of the bioequivalence test of each research drug in the sub-centers

Exclusion criteria

Exclusion criteria: comply with the exclusion criteria of the bioequivalence test of each research drug in the sub-centers

Design outcomes

Primary

MeasureTime frame
Gene detection;

Countries

China

Contacts

Public ContactZhao Xia

Peking University First Hospital

zxyjk@126.com+86 010-66110802

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026